© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Apr 27, 2015, the consensus forecast amongst 24 polled investment analysts covering Procter & Gamble Co advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Apr 27, 2015. The previous consensus forecast advised that Procter & Gamble Co would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 16 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 88.00, with a high estimate of 105.00 and a low estimate of 81.00. The median estimate represents a 9.18% increase from the last price of 80.60. View Full Financials
In 2014, Procter & Gamble Co reported a dividend of 2.45 USD, which represents a 7.02% increase over last year. The 13 analysts covering the company expect dividends of 2.60 USD for the upcoming fiscal year, an increase of 6.12%. View Full Financials
|Div growth (TTM)||+7.02 %|
On Apr 23, 2015, Procter & Gamble Co reported 3rd quarter 2015 earnings of 0.92 per share. This result was in line with the consensus of the 19 analysts following the company and under-performed last year's 3rd quarter results by 11.54 %. View Full Interim Financials
|Average growth rate||-2.54 %|
Procter & Gamble Co reported annual 2014 earnings of 4.22 per share on Aug 01, 2014. View Full Annual Financials
|Average growth rate||+0.74 %|
The Procter & Gamble Company had 3rd quarter 2015 revenues of 18.14bn. This missed the 18.49bn consensus estimate of the 16 analysts following the company. This was 10.01 % below the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||-2.96 %|
The Procter & Gamble Company had revenues for the full year 2014 of 83.06bn. This was 1.31 % below the prior year's results. View Full Annual Financials
|Average growth rate||+1.30 %|